When you have too much 'bad' cholesterol (LDL) in your blood, it sticks to the walls of your arteries and builds up like gunk, making them narrow and stiff — which raises your chance of having a heart attack or stroke.
See the scientific wording
Elevated levels of low-density lipoprotein (LDL) cholesterol directly cause the development of atherosclerosis, which in turn increases the risk of cardiovascular disease.
There's disagreement
The 3 studies we reviewed point in different directions — there's no clear consensus.
What the research says
3 studies reviewedSupporting (1)
Systematic Review With Meta-AnalysisMeta-analysis2016
This study showed that when people lower their 'bad' cholesterol (LDL), their risk of heart attacks and strokes goes down — no matter how they lower it. That means high LDL cholesterol isn't just a marker, it's a direct cause of heart disease.
Contradicting (2)
Cohort StudyHuman2024
This study found that a protein called PCSK9 can cause artery damage through inflammation, even when cholesterol levels aren’t high — meaning high cholesterol isn’t the only way heart disease happens.
Cohort StudyHuman2020
This study didn’t raise LDL to see if it causes heart disease — instead, it changed how the body handles iron and found that lowered LDL led to less plaque. So it supports that LDL matters, but doesn’t prove high LDL alone directly causes the problem.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting, 2 contradicting studies
Related videos
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
When you have too much 'bad' cholesterol (LDL) in your blood, it sticks to the walls of your arteries and builds up like gunk, making them narrow and stiff — which raises your chance of having a heart attack or stroke.
Evidence from Studies
Supporting (1)
Community contributions welcome
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.
This study showed that when people lower their 'bad' cholesterol (LDL), their risk of heart attacks and strokes goes down — no matter how they lower it. That means high LDL cholesterol isn't just a marker, it's a direct cause of heart disease.
Contradicting (2)
Community contributions welcome
PCSK9 stimulates Syk, PKCδ, and NF-κB, leading to atherosclerosis progression independently of LDL receptor
This study found that a protein called PCSK9 can cause artery damage through inflammation, even when cholesterol levels aren’t high — meaning high cholesterol isn’t the only way heart disease happens.
The haemochromatosis gene Hfe and Kupffer cells control LDL cholesterol homeostasis and impact on atherosclerosis development.
This study didn’t raise LDL to see if it causes heart disease — instead, it changed how the body handles iron and found that lowered LDL led to less plaque. So it supports that LDL matters, but doesn’t prove high LDL alone directly causes the problem.
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Direct causal effect of LDL lowering on atherosclerosis progression and cardiovascular events
A double-blind, placebo-controlled trial in 10,000 high-risk adults (e.g., with familial hypercholesterolemia or established CVD) randomized to receive either a potent LDL-lowering therapy (e.g., inclisiran) to achieve LDL <40 mg/dL or placebo, with serial intravascular ultrasound or CT angiography to measure atherosclerotic plaque volume change over 5 years, and adjudicated major adverse cardiovascular events (MACE) as primary outcome.
Dose-response relationship between LDL reduction and CVD risk reduction across diverse populations
A meta-analysis pooling individual-level data from 50+ RCTs (n > 300,000 participants) with standardized LDL measurements and long-term follow-up (>5 years), using regression models to quantify the proportional reduction in MACE per 1 mmol/L (38.7 mg/dL) LDL reduction, adjusting for baseline risk, age, sex, and comorbidities.
Causal role of lifelong LDL exposure on atherosclerosis and CVD, independent of confounding
A large-scale Mendelian randomization study using genetic variants in LDLR, PCSK9, HMGCR, and APOB as instrumental variables in >500,000 individuals from biobanks (e.g., UK Biobank), measuring lifetime LDL exposure via genetic scores and linking to coronary artery calcification (CAC) scores, carotid intima-media thickness, and incident CVD events over 15+ years.
Mechanistic causality of LDL in atherosclerosis development
A study using LDL receptor-knockout rabbits or ApoE-knockout mice fed a high-fat diet, with one group receiving an LDL-lowering monoclonal antibody (e.g., anti-PCSK9) and another receiving control IgG, measuring aortic lesion size, plaque composition, and endothelial dysfunction over 12 weeks under controlled conditions.
Temporal association between LDL levels and atherosclerosis progression in general population
A prospective cohort of 20,000 healthy adults aged 30–50 followed for 20+ years with repeated LDL measurements, annual carotid ultrasound or CAC scoring, and adjudicated CVD events, controlling for smoking, BP, diabetes, and HDL, to assess whether higher LDL predicts faster plaque accumulation and event onset.